Related Experiment Video
Updated: Jan 16, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Multi-Target Modulation of Polyphenols in Diabetic Kidney Disease Therapeutics: A Comprehensive Review
Esienanwan E Efiong1,2,3, Emmanuel Effa4, Esther Peters5
1Research Unit of Molecular Epidemiology Institute of Epidemiology, Helmholtz Zentrum München Neuherberg Germany.
Polyphenols show promise for treating diabetic kidney disease (DKD) by targeting its complex causes. Further clinical trials are needed to confirm their safety and effectiveness in managing this diabetes complication.
Area of Science:
- Nephrology
- Pharmacology
- Diabetology
Background:
- Diabetic kidney disease (DKD) is a major diabetes complication causing kidney failure.
- Current treatments for DKD, while advanced, often fail to halt disease progression.
- There's a critical need for novel therapies targeting DKD's underlying mechanisms.
Purpose of the Study:
- To review polyphenol classes with demonstrated nephroprotective effects in DKD.
- To highlight how polyphenols target multiple pathways involved in DKD pathogenesis.
- To explore the potential of polyphenols in integrative DKD management.
Main Methods:
- Literature search conducted from September 2024 to April 2025.
- Focused on studies investigating polyphenol effects in vitro, in vivo, and clinical trials.
- Analyzed interconnected pathways and molecular mediators regulated by polyphenols.
Main Results:
- Polyphenols exhibit nephroprotective properties against DKD.
- These compounds target multiple molecular mediators and pathways crucial to DKD.
- A multi-target approach using polyphenols may improve kidney function.
Conclusions:
- Polyphenols offer a promising therapeutic avenue for DKD.
- Integrating phytomedicine with conventional care could enhance DKD management.
- More clinical trials are essential to validate polyphenol efficacy and safety in DKD.
More Related Videos
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Related Concept Videos
Heart Failure Drugs: Diuretics
Antihypertensive Drugs: Potassium-Sparing Diuretics
Chronic Kidney Disease III: Interprofessional Care
Dipeptidyl Peptidase 4 Inhibitors
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Chronic Kidney Disease I: Introduction